Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection
Mucosal-associated invariant T (MAIT) cells, defined as CD161 TCR iVα7.2 T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chron...
Saved in:
Published in | Frontiers in immunology Vol. 9; p. 472 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
19.03.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Mucosal-associated invariant T (MAIT) cells, defined as CD161
TCR iVα7.2
T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3
CD161
TCR iVα7.2
MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2
CD161
MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4
T cells and MAIT cells and with CD57 on CD8
T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2
MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1. |
---|---|
AbstractList | Mucosal-associated invariant T (MAIT) cells, defined as CD161
++
TCR iVα7.2
+
T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3
+
CD161
++
TCR iVα7.2
+
MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2
+
CD161
+
MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4
+
T cells and MAIT cells and with CD57 on CD8
+
T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2
+
MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1. Mucosal-associated invariant T (MAIT) cells, defined as CD161++TCR iVα7.2+ T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3+CD161++TCR iVα7.2+ MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2+ CD161+ MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4+ T cells and MAIT cells and with CD57 on CD8+ T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2+ MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1.Mucosal-associated invariant T (MAIT) cells, defined as CD161++TCR iVα7.2+ T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3+CD161++TCR iVα7.2+ MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2+ CD161+ MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4+ T cells and MAIT cells and with CD57 on CD8+ T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2+ MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1. Mucosal-associated invariant T (MAIT) cells, defined as CD161++TCR iVα7.2+ T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3+CD161++TCR iVα7.2+ MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2+ CD161+ MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4+ T cells and MAIT cells and with CD57 on CD8+ T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2+ MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1. Mucosal-associated invariant T (MAIT) cells, defined as CD161 TCR iVα7.2 T cells, play an important role in the innate defense against bacterial infections, and their functionality is impaired in chronic viral infections. Here, we investigated the frequency and functional role of MAIT cells in chronic hepatitis B virus (HBV) infection. The peripheral CD3 CD161 TCR iVα7.2 MAIT cells in chronic HBV-infected patients and healthy controls were phenotypically characterized based on CD57, PD-1, TIM-3, and CTLA-4, as well as HLA-DR and CD38 expression. The frequency of MAIT cells was significantly decreased among chronic HBV-infected individuals as compared to controls. Expression of CD57, PD-1, CTLA-4, as well as HLA-DR and CD38 on MAIT cells was significantly elevated in chronic HBV-infected individuals relative to controls. The percentage of T cell receptor (TCR) iVα7.2 CD161 MAIT cells did not correlate with HBV viral load but inversely with HLA-DR on CD4 T cells and MAIT cells and with CD57 on CD8 T cells suggesting that decrease of MAIT cells may not be attributed to direct infection by HBV but driven by HBV-induced chronic immune activation. The percentage and expression levels of PD-1 as well as CTLA-4 on MAIT cells inversely correlated with plasma HBV-DNA levels, which may suggest either a role for MAIT cells in the control of HBV infection or the effect of HBV replication in the liver on MAIT cell phenotype. We report that decrease of TCR iVα7.2 MAIT cells in the peripheral blood and their functions were seemingly impaired in chronic HBV-infected patients likely because of the increased expression of PD-1. |
Author | Murugesan, Amudhan Vadivelu, Jamuna Velu, Vijayakumar Ansari, Abdul W. Batran, Rami Al Vignesh, Ramachandran Shankar, Esaki M. Tan, Hong Y. Larsson, Marie Enström, Philip F. Chattopadhyay, Indranil Ussher, James E. Rajarajeswaran, Jayakumar Kamarulzaman, Adeeba Saeidi, Alireza Rosmawati, Mohamed Vasuki, V. Yong, Yean K. |
AuthorAffiliation | 1 Laboratory Center, Xiamen University Malaysia , Sepang , Malaysia 14 Department of Microbiology and Immunology, Emory Vaccine Center , Atlanta, GA , United States 9 The Government Theni Medical College and Hospital , Theni , India 15 Division of Infection Biology, Department of Life Sciences, Central University of Tamil Nadu , Thiruvarur , India 10 Laboratory-Based Department, Universiti Kuala Lumpur , Ipoh , Malaysia 3 China-ASEAN Institute of Marine Science (CAMS), Xiamen University Malaysia , Sepang , Malaysia 7 Department of Microbiology, The Government Thiruvarur Medical College and Hospital , Thiruvarur , India 11 Center of Excellence for Research in AIDS, University of Malaya , Kuala Lumpur , Malaysia 2 Department of Medicine, University of Malaya Medical Centre , Kuala Lumpur , Malaysia 4 Department of Traditional Chinese Medicine, Xiamen University Malaysia , Sepang , Malaysia 12 Department of Molecular Medicine, Faculty of Medicine, University of Malaya , Kuala Lumpur , Malaysia 6 Dep |
AuthorAffiliation_xml | – name: 4 Department of Traditional Chinese Medicine, Xiamen University Malaysia , Sepang , Malaysia – name: 6 Department of Medical Microbiology, Faculty of Medicine, University of Malaya , Kuala Lumpur , Malaysia – name: 8 Division of Molecular Cancer Biology, Department of Life Sciences, Central University of Tamil Nadu , Thiruvarur , India – name: 3 China-ASEAN Institute of Marine Science (CAMS), Xiamen University Malaysia , Sepang , Malaysia – name: 10 Laboratory-Based Department, Universiti Kuala Lumpur , Ipoh , Malaysia – name: 5 Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University , Linköping , Sweden – name: 14 Department of Microbiology and Immunology, Emory Vaccine Center , Atlanta, GA , United States – name: 12 Department of Molecular Medicine, Faculty of Medicine, University of Malaya , Kuala Lumpur , Malaysia – name: 15 Division of Infection Biology, Department of Life Sciences, Central University of Tamil Nadu , Thiruvarur , India – name: 1 Laboratory Center, Xiamen University Malaysia , Sepang , Malaysia – name: 7 Department of Microbiology, The Government Thiruvarur Medical College and Hospital , Thiruvarur , India – name: 11 Center of Excellence for Research in AIDS, University of Malaya , Kuala Lumpur , Malaysia – name: 16 Department of Microbiology, Central University of Tamil Nadu , Thiruvarur , India – name: 13 Department of Microbiology and Immunology, University of Otago , Dunedin , New Zealand – name: 2 Department of Medicine, University of Malaya Medical Centre , Kuala Lumpur , Malaysia – name: 9 The Government Theni Medical College and Hospital , Theni , India |
Author_xml | – sequence: 1 givenname: Yean K. surname: Yong fullname: Yong, Yean K. – sequence: 2 givenname: Alireza surname: Saeidi fullname: Saeidi, Alireza – sequence: 3 givenname: Hong Y. surname: Tan fullname: Tan, Hong Y. – sequence: 4 givenname: Mohamed surname: Rosmawati fullname: Rosmawati, Mohamed – sequence: 5 givenname: Philip F. surname: Enström fullname: Enström, Philip F. – sequence: 6 givenname: Rami Al surname: Batran fullname: Batran, Rami Al – sequence: 7 givenname: V. surname: Vasuki fullname: Vasuki, V. – sequence: 8 givenname: Indranil surname: Chattopadhyay fullname: Chattopadhyay, Indranil – sequence: 9 givenname: Amudhan surname: Murugesan fullname: Murugesan, Amudhan – sequence: 10 givenname: Ramachandran surname: Vignesh fullname: Vignesh, Ramachandran – sequence: 11 givenname: Adeeba surname: Kamarulzaman fullname: Kamarulzaman, Adeeba – sequence: 12 givenname: Jayakumar surname: Rajarajeswaran fullname: Rajarajeswaran, Jayakumar – sequence: 13 givenname: Abdul W. surname: Ansari fullname: Ansari, Abdul W. – sequence: 14 givenname: Jamuna surname: Vadivelu fullname: Vadivelu, Jamuna – sequence: 15 givenname: James E. surname: Ussher fullname: Ussher, James E. – sequence: 16 givenname: Vijayakumar surname: Velu fullname: Velu, Vijayakumar – sequence: 17 givenname: Marie surname: Larsson fullname: Larsson, Marie – sequence: 18 givenname: Esaki M. surname: Shankar fullname: Shankar, Esaki M. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29616020$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kt9u0zAUxiM0xMbYPVfIl0hViv_ESXqDtKWFVipiQtVuLcc5aT2ldrGdsj4WLwKvhNtuqEPCN7bO-c7vk46_18mZsQaS5C3BQ8bK0YdWr9f9kGJSDjHOCvoiuSB5nqWM0uzs5H2eXHl_j-PJRowx_io5p6Oc5Jjii-T3dLcBl04eNg6819Yg26LbcUrQzKNr763SMkCDfuiwQmEFaA5b6PxeNXlYyd7vm9I0aLzzbW9UiAjZodsVGBsi-qCstFN9J4M2S1SNSU4Gg0X1Dem7Xz-LIR2gL72yXnbpid_MbKXT0gS0QBV00VEbVK2cNVqhKWwiLGiPbtCddr2P8hYO3m-Sl63sPFw93pfJ4tNkUU3T-dfPs-p6nio2oiElGNqyoDXkdT3ikmKgdc05kdAywOWoLIHThhUYCK-blpNcUeC4zWoGBZPsMpkdsY2V92Lj9Fq6nbBSi0PBuqWQLmjVgWANRINIUpRnkhd1ITFtikY2pIm_UUfWxyNr09draBSY4GT3DPq8Y_RKLO1W8DIvM84j4P0jwNnvPfgg1tqruDRpwPZeUExJwSjJ99J3p15_TZ4CEQX5UaCc9d5BK5QOcr_ZaK07QbDYh08cwif24ROH8MVB_M_gE_u_I38AvpLgpQ |
CitedBy_id | crossref_primary_10_1089_gtmb_2018_0092 crossref_primary_10_1016_j_virs_2023_10_007 crossref_primary_10_1371_journal_pone_0303945 crossref_primary_10_1016_j_coviro_2021_04_003 crossref_primary_10_1186_s12935_022_02703_x crossref_primary_10_3390_cancers13071502 crossref_primary_10_1186_s12958_019_0524_5 crossref_primary_10_1007_s00430_018_0547_0 crossref_primary_10_1111_exd_13952 crossref_primary_10_1093_cei_uxad102 crossref_primary_10_3389_fimmu_2019_01888 crossref_primary_10_1016_j_molimm_2018_08_022 crossref_primary_10_3389_fimmu_2020_00490 crossref_primary_10_1155_2019_1356540 crossref_primary_10_1002_1873_3468_13488 crossref_primary_10_3389_fcimb_2024_1488527 crossref_primary_10_1038_s41590_019_0444_8 crossref_primary_10_1136_jitc_2021_003685 crossref_primary_10_3389_fimmu_2019_03053 crossref_primary_10_1002_ijc_33411 crossref_primary_10_1186_s12985_022_01777_3 crossref_primary_10_1016_j_isci_2024_108801 crossref_primary_10_1080_1744666X_2023_2198209 crossref_primary_10_1111_liv_15445 crossref_primary_10_14309_ctg_0000000000000052 crossref_primary_10_3389_fimmu_2020_01961 crossref_primary_10_3390_ijms21072379 crossref_primary_10_1111_jvh_13108 crossref_primary_10_1111_liv_15054 crossref_primary_10_3389_fimmu_2020_01691 crossref_primary_10_1186_s12935_018_0627_7 crossref_primary_10_3390_vaccines11030681 crossref_primary_10_1186_s40425_019_0749_z crossref_primary_10_1089_vim_2020_0149 crossref_primary_10_3389_fimmu_2022_931764 crossref_primary_10_5812_hepatmon_94377 crossref_primary_10_1111_jvh_13341 crossref_primary_10_1111_jvh_13040 crossref_primary_10_1016_j_molimm_2020_12_007 crossref_primary_10_3748_wjg_v27_i25_3790 crossref_primary_10_1186_s12958_021_00861_7 crossref_primary_10_3389_fimmu_2019_03127 crossref_primary_10_3390_cancers13184647 crossref_primary_10_3390_vaccines13020155 crossref_primary_10_3389_fmicb_2022_975584 crossref_primary_10_3748_wjg_v27_i25_3705 crossref_primary_10_1158_1078_0432_CCR_18_3040 crossref_primary_10_1089_dna_2018_4278 crossref_primary_10_1371_journal_pone_0228302 crossref_primary_10_4049_jimmunol_2100522 crossref_primary_10_3390_cancers12020413 crossref_primary_10_1186_s13578_021_00664_8 crossref_primary_10_1016_j_micpath_2021_105231 crossref_primary_10_1093_jleuko_qiad129 crossref_primary_10_1016_j_ebiom_2024_105138 crossref_primary_10_1016_j_jcmgh_2022_12_014 crossref_primary_10_3748_wjg_v26_i31_4703 crossref_primary_10_3389_fimmu_2018_02569 crossref_primary_10_3389_fimmu_2023_1160943 crossref_primary_10_1038_s41598_020_69358_4 crossref_primary_10_3390_cancers13030404 crossref_primary_10_3390_microorganisms9020296 crossref_primary_10_1016_j_smim_2022_101661 crossref_primary_10_1016_j_jhepr_2023_100812 crossref_primary_10_1186_s40364_023_00482_9 crossref_primary_10_3389_fonc_2021_731175 crossref_primary_10_3389_fimmu_2023_1114605 crossref_primary_10_1007_s00281_022_00949_1 crossref_primary_10_3390_v12091051 crossref_primary_10_1002_jmv_29142 |
Cites_doi | 10.1186/1471-230X-12-109 10.1053/jhep.2003.50208 10.1177/1753425917714854 10.1371/journal.pone.0136476 10.1073/pnas.0903196106 10.1189/jlb.4RU0216-084R 10.1002/hep.22956 10.1002/eji.201141852 10.1016/j.jhep.2008.08.026 10.1016/j.cellimm.2015.10.009 10.1111/eci.12581 10.1073/pnas.0914839107 10.1084/jem.20022235 10.1038/nature11605 10.1128/JVI.02844-06 10.1136/gutjnl-2011-301073 10.1097/MD.0000000000001134 10.1111/j.1572-0241.2006.00647.x 10.1056/NEJMoa043470 10.1002/hep.23173 10.1371/journal.pone.0105703 10.1371/journal.ppat.1004210 10.1016/S0140-6736(12)61728-0 10.1136/gut.2006.093906 10.1038/ncomms4866 10.1371/journal.pone.0124659 10.1016/j.virol.2014.12.033 10.1002/hep.23936 10.1016/j.apsb.2014.05.002 10.4049/jimmunol.178.10.6634 10.3748/wjg.v13.i14.2104 10.1016/S0168-8278(01)00028-9 10.1084/jem.20112095 10.1093/carcin/bgm252 10.1046/j.1440-1746.2003.02976.x 10.1073/pnas.0406282101 10.3748/wjg.14.3059 10.1016/j.cellimm.2015.05.005 10.1002/hep.24249 10.1002/eji.201343509 10.1038/ni1515 10.1371/journal.pone.0077780 10.1371/journal.pone.0047648 10.1182/blood-2010-08-303339 10.1056/NEJMra031087 10.1016/j.vaccine.2007.09.072 10.1038/ni.1679 10.1182/blood-2012-06-436436 10.1053/j.gastro.2005.11.016 10.1038/nature04444 10.1038/ni.3298 10.1038/mi.2014.81 10.1111/j.1365-2893.2005.00603.x 10.1371/journal.ppat.1003784 10.1016/j.coi.2013.01.005 10.1182/blood-2010-11-317297 10.1038/nature13160 10.1093/jnci/djn243 10.4254/wjh.v7.i12.1660 |
ContentType | Journal Article |
Copyright | Copyright © 2018 Yong, Saeidi, Tan, Rosmawati, Enström, Batran, Vasuki, Chattopadhyay, Murugesan, Vignesh, Kamarulzaman, Rajarajeswaran, Ansari, Vadivelu, Ussher, Velu, Larsson and Shankar. 2018 Yong, Saeidi, Tan, Rosmawati, Enström, Batran, Vasuki, Chattopadhyay, Murugesan, Vignesh, Kamarulzaman, Rajarajeswaran, Ansari, Vadivelu, Ussher, Velu, Larsson and Shankar |
Copyright_xml | – notice: Copyright © 2018 Yong, Saeidi, Tan, Rosmawati, Enström, Batran, Vasuki, Chattopadhyay, Murugesan, Vignesh, Kamarulzaman, Rajarajeswaran, Ansari, Vadivelu, Ussher, Velu, Larsson and Shankar. 2018 Yong, Saeidi, Tan, Rosmawati, Enström, Batran, Vasuki, Chattopadhyay, Murugesan, Vignesh, Kamarulzaman, Rajarajeswaran, Ansari, Vadivelu, Ussher, Velu, Larsson and Shankar |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fimmu.2018.00472 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
ExternalDocumentID | oai_doaj_org_article_3de5a270ec254a57b7a02d7dad1d335b PMC5868455 29616020 10_3389_fimmu_2018_00472 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Institut Pengurusan dan Pemantauan Penyelidikan, Universiti Malaya grantid: FG019-17AFR |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c392t-10ef872be6bb95a20e2bb551aef3e08988e52d370e15bdf516c2e50f4b3e73a3 |
IEDL.DBID | M48 |
ISSN | 1664-3224 |
IngestDate | Wed Aug 27 01:23:48 EDT 2025 Thu Aug 21 17:23:51 EDT 2025 Thu Jul 10 18:34:46 EDT 2025 Mon Jul 21 05:59:49 EDT 2025 Tue Jul 01 01:35:18 EDT 2025 Thu Apr 24 22:59:38 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | immunosenescence HLA-DR HBV infection mucosal-associated invariant T cells CTLA-4 immune exhaustion PD-1 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c392t-10ef872be6bb95a20e2bb551aef3e08988e52d370e15bdf516c2e50f4b3e73a3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 Reviewed by: Masaaki Miyazawa, Kindai University, Japan; Hridayesh Prakash, All India Institute of Medical Sciences, India These authors have contributed equally to the experimental work and writing of the manuscript. Edited by: Jason Paul Gigley, University of Wyoming, United States Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2018.00472 |
PMID | 29616020 |
PQID | 2021732165 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_3de5a270ec254a57b7a02d7dad1d335b pubmedcentral_primary_oai_pubmedcentral_nih_gov_5868455 proquest_miscellaneous_2021732165 pubmed_primary_29616020 crossref_citationtrail_10_3389_fimmu_2018_00472 crossref_primary_10_3389_fimmu_2018_00472 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-03-19 |
PublicationDateYYYYMMDD | 2018-03-19 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-19 day: 19 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2018 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Kjer-Nielsen (B40) 2012; 491 Said (B9) 2015; 7 Chen (B48) 2007; 178 Pol (B3) 2001; 34 Vandepapeliere (B4) 2007; 25 Le Bourhis (B19) 2013; 25 B28 Blackburn (B35) 2009; 10 Wenjin (B33) 2012; 12 Chen (B54) 2006; 101 Barber (B50) 2006; 439 Liu (B57) 2008; 14 Godfrey (B45) 2015; 16 Loggi (B11) 2009; 50 Boni (B13) 2007; 81 Liaw (B32) 2003; 18 Ussher (B43) 2014; 44 Perrillo (B5) 2009; 49 Lau (B6) 2005; 352 Bertoletti (B8) 2012; 61 Nebbia (B15) 2012; 7 Barathan (B27) 2016; 46 Saeidi (B39) 2016; 100 Iloeje (B55) 2006; 130 Lozano (B1) 2012; 380 Kahan (B31) 2015; 47 Wu (B16) 2012; 42 Chen (B12) 2004; 101 Mommeja-Marin (B59) 2003; 37 Saeidi (B30) 2015; 297 Yuan (B53) 2005; 12 Yang (B58) 2008; 100 Quan (B51) 2015; 10 Reantragoon (B20) 2012; 209 Yamamoto (B37) 2011; 117 Kurioka (B44) 2015; 8 Lepore (B21) 2014; 5 Jo (B42) 2014; 10 Cosgrove (B23) 2013; 121 Wu (B56) 2008; 29 Raziorrouh (B38) 2014; 9 Ganem (B10) 2004; 350 Corbett (B41) 2014; 509 Huang (B18) 2009; 106 Karrar (B47) 2007; 56 Seung (B52) 2013; 8 Saeidi (B29) 2015; 10 Yong (B26) 2017; 23 Raziorrouh (B34) 2010; 52 Kassel (B49) 2009; 50 Shao (B60) 2007; 13 Kaufmann (B36) 2007; 8 Billerbeck (B22) 2010; 107 Dusseaux (B17) 2011; 117 Ussher (B24) 2015; 94 Saeidi (B25) 2015; 298 Iwai (B46) 2003; 198 Chang (B7) 2014; 4 Bertoletti (B2) 2013; 9 Schurich (B14) 2011; 53 |
References_xml | – volume: 12 start-page: 109 year: 2012 ident: B33 article-title: Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-12-109 – volume: 37 start-page: 1309 year: 2003 ident: B59 article-title: Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature publication-title: Hepatology doi: 10.1053/jhep.2003.50208 – volume: 23 start-page: 459 year: 2017 ident: B26 article-title: Decrease of CD69 levels on TCR Valpha7.2(+)CD4(+) innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients publication-title: Innate Immun doi: 10.1177/1753425917714854 – volume: 10 start-page: e0136476 year: 2015 ident: B51 article-title: PD-1 blockade can restore functions of T-cells in Epstein-Barr virus-positive diffuse large B-cell lymphoma in vitro publication-title: PLoS One doi: 10.1371/journal.pone.0136476 – volume: 106 start-page: 8290 year: 2009 ident: B18 article-title: MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0903196106 – volume: 100 start-page: 305 year: 2016 ident: B39 article-title: Functional role of mucosal-associated invariant T cells in HIV infection publication-title: J Leukoc Biol doi: 10.1189/jlb.4RU0216-084R – volume: 49 start-page: S103 year: 2009 ident: B5 article-title: Benefits and risks of interferon therapy for hepatitis B publication-title: Hepatology doi: 10.1002/hep.22956 – volume: 42 start-page: 1180 year: 2012 ident: B16 article-title: Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B publication-title: Eur J Immunol doi: 10.1002/eji.201141852 – volume: 50 start-page: 625 year: 2009 ident: B11 article-title: Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft publication-title: J Hepatol doi: 10.1016/j.jhep.2008.08.026 – volume: 298 start-page: 126 year: 2015 ident: B25 article-title: Regulation of CD8+ T-cell cytotoxicity in HIV-1 infection publication-title: Cell Immunol doi: 10.1016/j.cellimm.2015.10.009 – volume: 46 start-page: 170 year: 2016 ident: B27 article-title: Peripheral loss of CD8(+) CD161(++) TCRValpha7.2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients publication-title: Eur J Clin Invest doi: 10.1111/eci.12581 – volume: 107 start-page: 3006 year: 2010 ident: B22 article-title: Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0914839107 – volume: 198 start-page: 39 year: 2003 ident: B46 article-title: PD-1 inhibits antiviral immunity at the effector phase in the liver publication-title: J Exp Med doi: 10.1084/jem.20022235 – volume: 491 start-page: 717 year: 2012 ident: B40 article-title: MR1 presents microbial vitamin B metabolites to MAIT cells publication-title: Nature doi: 10.1038/nature11605 – volume: 81 start-page: 4215 year: 2007 ident: B13 article-title: Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection publication-title: J Virol doi: 10.1128/JVI.02844-06 – volume: 61 start-page: 1754 year: 2012 ident: B8 article-title: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection publication-title: Gut doi: 10.1136/gutjnl-2011-301073 – volume: 94 start-page: e1134 year: 2015 ident: B24 article-title: Molecular analyses define Valpha7.2-Jalpha33+ MAIT cell depletion in HIV infection: a case-control study publication-title: Medicine doi: 10.1097/MD.0000000000001134 – volume: 101 start-page: 1797 year: 2006 ident: B54 article-title: Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2006.00647.x – volume: 352 start-page: 2682 year: 2005 ident: B6 article-title: Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B publication-title: N Engl J Med doi: 10.1056/NEJMoa043470 – ident: B28 – volume: 50 start-page: 1625 year: 2009 ident: B49 article-title: Chronically inflamed livers up-regulate expression of inhibitory B7 family members publication-title: Hepatology doi: 10.1002/hep.23173 – volume: 9 start-page: e105703 year: 2014 ident: B38 article-title: Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules publication-title: PLoS One doi: 10.1371/journal.pone.0105703 – volume: 10 start-page: e1004210 year: 2014 ident: B42 article-title: Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1004210 – volume: 380 start-page: 2095 year: 2012 ident: B1 article-title: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61728-0 – volume: 56 start-page: 243 year: 2007 ident: B47 article-title: Human liver sinusoidal endothelial cells induce apoptosis in activated T cells: a role in tolerance induction publication-title: Gut doi: 10.1136/gut.2006.093906 – volume: 5 start-page: 3866 year: 2014 ident: B21 article-title: Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRbeta repertoire publication-title: Nat Commun doi: 10.1038/ncomms4866 – volume: 10 start-page: e0124659 year: 2015 ident: B29 article-title: Attrition of TCR Valpha7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression publication-title: PLoS One doi: 10.1371/journal.pone.0124659 – volume: 47 start-page: 180 year: 2015 ident: B31 article-title: T cell exhaustion during persistent viral infections publication-title: Virology doi: 10.1016/j.virol.2014.12.033 – volume: 52 start-page: 1934 year: 2010 ident: B34 article-title: The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function publication-title: Hepatology doi: 10.1002/hep.23936 – volume: 4 start-page: 248 year: 2014 ident: B7 article-title: Therapeutic strategies for a functional cure of chronic hepatitis B virus infection publication-title: Acta Pharm Sin B doi: 10.1016/j.apsb.2014.05.002 – volume: 178 start-page: 6634 year: 2007 ident: B48 article-title: B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B publication-title: J Immunol doi: 10.4049/jimmunol.178.10.6634 – volume: 13 start-page: 2104 year: 2007 ident: B60 article-title: Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B publication-title: World J Gastroenterol doi: 10.3748/wjg.v13.i14.2104 – volume: 34 start-page: 917 year: 2001 ident: B3 article-title: Efficacy and limitations of a specific immunotherapy in chronic hepatitis B publication-title: J Hepatol doi: 10.1016/S0168-8278(01)00028-9 – volume: 209 start-page: 761 year: 2012 ident: B20 article-title: Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor publication-title: J Exp Med doi: 10.1084/jem.20112095 – volume: 29 start-page: 106 year: 2008 ident: B56 article-title: Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men publication-title: Carcinogenesis doi: 10.1093/carcin/bgm252 – volume: 18 start-page: 246 year: 2003 ident: B32 article-title: Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy publication-title: J Gastroenterol Hepatol doi: 10.1046/j.1440-1746.2003.02976.x – volume: 101 start-page: 14913 year: 2004 ident: B12 article-title: A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0406282101 – volume: 14 start-page: 3059 year: 2008 ident: B57 article-title: A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China publication-title: World J Gastroenterol doi: 10.3748/wjg.14.3059 – volume: 297 start-page: 19 year: 2015 ident: B30 article-title: Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection publication-title: Cell Immunol doi: 10.1016/j.cellimm.2015.05.005 – volume: 53 start-page: 1494 year: 2011 ident: B14 article-title: Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection publication-title: Hepatology doi: 10.1002/hep.24249 – volume: 44 start-page: 195 year: 2014 ident: B43 article-title: CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner publication-title: Eur J Immunol doi: 10.1002/eji.201343509 – volume: 8 start-page: 1246 year: 2007 ident: B36 article-title: Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction publication-title: Nat Immunol doi: 10.1038/ni1515 – volume: 8 start-page: e77780 year: 2013 ident: B52 article-title: PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads publication-title: PLoS One doi: 10.1371/journal.pone.0077780 – volume: 7 start-page: e47648 year: 2012 ident: B15 article-title: Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection publication-title: PLoS One doi: 10.1371/journal.pone.0047648 – volume: 117 start-page: 1250 year: 2011 ident: B17 article-title: Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells publication-title: Blood doi: 10.1182/blood-2010-08-303339 – volume: 350 start-page: 1118 year: 2004 ident: B10 article-title: Hepatitis B virus infection – natural history and clinical consequences publication-title: N Engl J Med doi: 10.1056/NEJMra031087 – volume: 25 start-page: 8585 year: 2007 ident: B4 article-title: Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine publication-title: Vaccine doi: 10.1016/j.vaccine.2007.09.072 – volume: 10 start-page: 29 year: 2009 ident: B35 article-title: Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection publication-title: Nat Immunol doi: 10.1038/ni.1679 – volume: 121 start-page: 951 year: 2013 ident: B23 article-title: Early and nonreversible decrease of CD161++/MAIT cells in HIV infection publication-title: Blood doi: 10.1182/blood-2012-06-436436 – volume: 130 start-page: 678 year: 2006 ident: B55 article-title: Predicting cirrhosis risk based on the level of circulating hepatitis B viral load publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.11.016 – volume: 439 start-page: 682 year: 2006 ident: B50 article-title: Restoring function in exhausted CD8 T cells during chronic viral infection publication-title: Nature doi: 10.1038/nature04444 – volume: 16 start-page: 1114 year: 2015 ident: B45 article-title: The burgeoning family of unconventional T cells publication-title: Nat Immunol doi: 10.1038/ni.3298 – volume: 8 start-page: 429 year: 2015 ident: B44 article-title: MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets publication-title: Mucosal Immunol doi: 10.1038/mi.2014.81 – volume: 12 start-page: 373 year: 2005 ident: B53 article-title: The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B publication-title: J Viral Hepat doi: 10.1111/j.1365-2893.2005.00603.x – volume: 9 start-page: e1003784 year: 2013 ident: B2 article-title: Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control? publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003784 – volume: 25 start-page: 174 year: 2013 ident: B19 article-title: MAIT cells, surveyors of a new class of antigen: development and functions publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2013.01.005 – volume: 117 start-page: 4805 year: 2011 ident: B37 article-title: Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection publication-title: Blood doi: 10.1182/blood-2010-11-317297 – volume: 509 start-page: 361 year: 2014 ident: B41 article-title: T-cell activation by transitory neo-antigens derived from distinct microbial pathways publication-title: Nature doi: 10.1038/nature13160 – volume: 100 start-page: 1134 year: 2008 ident: B58 article-title: Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djn243 – volume: 7 start-page: 1660 year: 2015 ident: B9 article-title: Induced immunity against hepatitis B virus publication-title: World J Hepatol doi: 10.4254/wjh.v7.i12.1660 |
SSID | ssj0000493335 |
Score | 2.4559822 |
Snippet | Mucosal-associated invariant T (MAIT) cells, defined as CD161
TCR iVα7.2
T cells, play an important role in the innate defense against bacterial infections,... Mucosal-associated invariant T (MAIT) cells, defined as CD161++TCR iVα7.2+ T cells, play an important role in the innate defense against bacterial infections,... Mucosal-associated invariant T (MAIT) cells, defined as CD161 ++ TCR iVα7.2 + T cells, play an important role in the innate defense against bacterial... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 472 |
SubjectTerms | HBV infection HLA-DR immune exhaustion Immunology immunosenescence mucosal-associated invariant T cells PD-1 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NjtMwELbQSkhcEP-UP3klLqgKje04To5s21UXsWiFympvURxPaFDXRU2Ldh-LF4FXYiZJq3aF4MI1nmgszzjzjf1lhrHXOiysEGADUFEURFq4wCaJDkKA0qQOpHL0v_Ppx3jyOXp_oS92Wn0RJ6wtD9wu3EA50Lk0IRSYyuTaWJOH0hmXO-GU0pa-vhjzdpKpry3uVTja3ktiFpYOyuryck1ULuJORkbuxaGmXP-fMOZNquRO7Dm-x-52oJG_ayd7n90C_4DdbttIXj9kvyaYTC6D8VVHavV8UfKzUSD4Sc036w-O05krR8DHPxBTqCap8dWMCv_gYO4dH13XFOfa40F-NgO_oCPaRnJYLYum1Zf_wocjRHD9_nT4iVfnP3-Yt7LPT4n6ns-DHX0n_jtm4mg6PuVDmKPGyvOuGi-fAHG5V1XNj_h5tVzXKN7ywvwjNj0eT4eToGvUEBQIr1b4KYcyMdJCbG2K1gpBWotQLIdSQZikSQJaOoVGFNq6Uou4kKDDMrIKjMrVY3bgFx6eMh4WkUhCJcvUCErurHR5qqOiMIkFaUyPDTZWy4quiDn10phnmMyQnbPGzhnZOWvs3GNvtm98awt4_EX2iBxhK0elt5sH6JBZ55DZvxyyxw43bpThVqX7l9zDYl2jIsz_lBSx7rEnrVttVck0FjFC9x4zew63N5f9EV_NmnLgOomTSOtn_2Pyz9kdWg4i2Yn0BTtYLdfwElHXyr5qNthvwBUu_Q priority: 102 providerName: Directory of Open Access Journals |
Title | Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29616020 https://www.proquest.com/docview/2021732165 https://pubmed.ncbi.nlm.nih.gov/PMC5868455 https://doaj.org/article/3de5a270ec254a57b7a02d7dad1d335b |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fb9MwELfQEBIviP-UP5OReEFVttiO4-QBIdZ2dIiiCXXT3qI4vqxBnQtJi9qPxReBr8Q5ScuKKiReIiW-xHHunPud88sdIa-kn2nGQHsggsALJDOejiLp-QC5ig1wYdz_zqNP4fAs-HAhL_78Ht0-wGpnaOfqSZ2V04Plt9VbnPBvXMSJ_vYwL66uFo6l5WiRgcIX8k30S8rVMxi1YP9Lg4WFqCtusjAMPLTkoPluufMiW36qTue_C4P-TaW85puO75I7Laik7xoruEdugL1PbjVlJlcPyK8hBpulN1i2pFdLZzk97XuMnlR0rR8w1K3JUgSE9KNjElVOarCcuMRA2JhaQ_uryvnBZvmQnk7AztwSbi3ZK8qsLgVmL2mvjwiv2x33PtPi_OcPdcC7dOSo8enUu9bfif2OkTqqlo5pD6bYY2Fpm62XDsFxvedFRY_oeVEuKhRveGP2IRkfD8a9odcWcvAyhF9zfNVDHimuIdQ6lin3gWuNUC2FXIAfxVEEkhuhfGBSm1yyMOMg_TzQApRIxSOyZ2cWnhDqZwGLfMHzWDEX_Glu0lgGWaYiDVypDjlcay3J2iTnrtbGNMFgx-k5qfWcOD0ntZ475PXmjK9Ngo9_yB45Q9jIudTc9YFZeZm0Mz0RBnCIOJYMY-9UKq1SnxtlUsMMmp_ukJdrM0pwKrvvM6mF2aLCjjA-FJyFskMeN2a16YrHIQsR2neI2jK4rXvZbrHFpE4XLqMwCqR8-h8DfUZuux3HtWPxc7I3LxfwAsHXXO_Xixa4fX_B9uv59RvW3TFP |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyper-Expression+of+PD-1+Is+Associated+with+the+Levels+of+Exhausted+and+Dysfunctional+Phenotypes+of+Circulating+CD161%2B%2BTCR+iV%CE%B17.2%2B+Mucosal-Associated+Invariant+T+Cells+in+Chronic+Hepatitis+B+Virus+Infection&rft.jtitle=Frontiers+in+immunology&rft.au=Yong%2C+Yean+K.&rft.au=Saeidi%2C+Alireza&rft.au=Tan%2C+Hong+Y.&rft.au=Rosmawati%2C+Mohamed&rft.date=2018-03-19&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=9&rft_id=info:doi/10.3389%2Ffimmu.2018.00472&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fimmu_2018_00472 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |